The database platform developer will embark on international expansion with funding raised from investors including Dell Technologies Capital and Wipro Ventures.

Telus’ corporate venturing unit has led a $23.7m round for the Canadian online pharmacy as it seeks to take its coverage nationwide.

Access Biotechnology and returning investor Eli Lilly were among the participants in a series B round for the RNA-based drug developer.

Acorn Bioventures has led a series B round for the cancer-focused biopharmaceutical spinout of CU Boulder.

Zhongnan Capital and SAIC's FOF Hengxu Capital contributed to a $15.5m round that will support technology development and hiring.

Nationwide Ventures co-led a $15m series B round for the health data platform developer that included Aflac Corporate Ventures and Epsilon Health Investors.

NetEase and Sony Music Entertainment contributed to a round that boosted the livestreaming platform developer's overall funding to $22m.

The low-code app app development software provider's eight-figure round included BAI and SIG Asia.

Seiko Epson’s EP-GB fund and Dai-ichi Life helped provide $17.1m for Gitai as it prepares a demonstration of its space robotics technology.

Hovione Scientia and Consort Medical-backed Oxular has secured funding that will support phase 2 trials for a treatment for diabetic macular oedema.